▶ 調査レポート

コレラワクチンの世界市場レポート2020

• 英文タイトル:Global Cholera Vaccine Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。コレラワクチンの世界市場レポート2020 / Global Cholera Vaccine Sales Market Report 2020 / 20QY06-01909資料のイメージです。• レポートコード:20QY06-01909
• 出版社/出版日:QYResearch / 2020年6月1日
• レポート形態:英文、PDF、135ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥428,000 (USD4,000)▷ お問い合わせ
  Multi User¥642,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥856,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、コレラワクチンのグローバル市場について種類別(デュコラル、シャンコール、ヴァクスコラ、その他)、用途別(病院、科学研究、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・コレラワクチン市場の概要
・世界の主要地域別コレラワクチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のコレラワクチン市場規模2015-2026:種類別(デュコラル、シャンコール、ヴァクスコラ、その他)
・世界のコレラワクチン市場規模2015-2026:用途別(病院、科学研究、その他)
・コレラワクチンの北米市場規模2015-2020
・コレラワクチンのヨーロッパ市場規模2015-2020
・コレラワクチンの中国市場規模2015-2020
・コレラワクチンの日本市場規模2015-2020
・コレラワクチンの東南アジア市場規模2015-2020
・コレラワクチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Valneva、PaxVax、Shantha Biotechnics Limited、Celldex Therapeutics、Merck、Ceva Asia)
・コレラワクチンの製造コスト分析
・販売チャネル、流通業者、顧客
・コレラワクチンの市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Cholera Vaccine Market
The global Cholera Vaccine market was valued at US$ 66 million in 2019 and will reach US$ 121.1 million by the end of 2026, growing at a CAGR of 8.8% during 2020-2026.
Global Cholera Vaccine Scope and Market Size
The global Cholera Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cholera Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Cholera Vaccine market is segmented into
Dukoral
Shanchol
Vaxchora
Others

Segment by Application, the Cholera Vaccine market is segmented into
Hospital
Scientific Research
Others
The Cholera Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Cholera Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cholera Vaccine Market Share Analysis
Cholera Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cholera Vaccine business, the date to enter into the Cholera Vaccine market, Cholera Vaccine product introduction, recent developments, etc.
The major vendors covered:
Valneva
PaxVax
Shantha Biotechnics Limited
Celldex Therapeutics
Merck
Ceva Asia

レポート目次

Table of Contents

1 Cholera Vaccine Market Overview
1.1 Cholera Vaccine Product Scope
1.2 Cholera Vaccine Segment by Type
1.2.1 Global Cholera Vaccine Sales by Type (2020-2026)
1.2.2 Dukoral
1.2.3 Shanchol
1.2.4 Vaxchora
1.2.5 Others
1.3 Cholera Vaccine Segment by Application
1.3.1 Global Cholera Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Cholera Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cholera Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Cholera Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Cholera Vaccine Price Trends (2015-2026)

2 Cholera Vaccine Estimate and Forecast by Region
2.1 Global Cholera Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cholera Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cholera Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Cholera Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Cholera Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cholera Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cholera Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cholera Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Cholera Vaccine Estimates and Projections (2015-2026)
2.4.3 China Cholera Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Cholera Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cholera Vaccine Estimates and Projections (2015-2026)
2.4.6 India Cholera Vaccine Estimates and Projections (2015-2026)
3 Global Cholera Vaccine Competition Landscape by Players
3.1 Global Top Cholera Vaccine Players by Sales (2015-2020)
3.2 Global Top Cholera Vaccine Players by Revenue (2015-2020)
3.3 Global Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholera Vaccine as of 2019)
3.4 Global Cholera Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Cholera Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cholera Vaccine Players (Opinion Leaders)
4 Global Cholera Vaccine Market Size by Type
4.1 Global Cholera Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Cholera Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Cholera Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Cholera Vaccine Price by Type (2014-2020)
4.2 Global Cholera Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cholera Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Cholera Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Cholera Vaccine Price Forecast by Type (2021-2026)
5 Global Cholera Vaccine Market Size by Application
5.1 Global Cholera Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Cholera Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Cholera Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Cholera Vaccine Price by Application (2015-2020)
5.2 Global Cholera Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cholera Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Cholera Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Cholera Vaccine Price Forecast by Application (2021-2026)

3 North America Cholera Vaccine Market Facts & Figures
3.2 North America Cholera Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Cholera Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Cholera Vaccine Sales Market Share by Application (2015-2020)

4 Europe Cholera Vaccine Market Facts & Figures
4.2 Europe Cholera Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Cholera Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Cholera Vaccine Sales Market Share by Application (2015-2020)

5 China Cholera Vaccine Market Facts & Figures
5.2 China Cholera Vaccine Sales Market Share by Company (2015-2020)
5.3 China Cholera Vaccine Sales Market Share by Type (2015-2020)
5.4 China Cholera Vaccine Sales Market Share by Application (2015-2020)

6 Japan Cholera Vaccine Market Facts & Figures
6.2 Japan Cholera Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Cholera Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Cholera Vaccine Sales Market Share by Application (2015-2020)

7 Southeast Asia Cholera Vaccine Market Facts & Figures
7.2 Southeast Asia Cholera Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Cholera Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Cholera Vaccine Sales Market Share by Application (2015-2020)

8 India Cholera Vaccine Market Facts & Figures
8.2 India Cholera Vaccine Sales Market Share by Company (2015-2020)
8.3 India Cholera Vaccine Sales Market Share by Type (2015-2020)
8.4 India Cholera Vaccine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Cholera Vaccine Business
12.1 Valneva
12.1.1 Valneva Cholera Vaccine Corporation Information
12.1.2 Valneva Cholera Vaccine Business Overview and Total Revenue
12.1.3 Valneva Cholera Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Valneva Cholera Vaccine Products Offered
12.1.5 Valneva Recent Development
12.2 PaxVax
12.2.1 PaxVax Cholera Vaccine Corporation Information
12.2.2 PaxVax Cholera Vaccine Business Overview and Total Revenue
12.2.3 PaxVax Cholera Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 PaxVax Cholera Vaccine Products Offered
12.2.5 PaxVax Recent Development
12.3 Shantha Biotechnics Limited
12.3.1 Shantha Biotechnics Limited Cholera Vaccine Corporation Information
12.3.2 Shantha Biotechnics Limited Cholera Vaccine Business Overview and Total Revenue
12.3.3 Shantha Biotechnics Limited Cholera Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Shantha Biotechnics Limited Cholera Vaccine Products Offered
12.3.5 Shantha Biotechnics Limited Recent Development
12.4 Celldex Therapeutics
12.4.1 Celldex Therapeutics Cholera Vaccine Corporation Information
12.4.2 Celldex Therapeutics Cholera Vaccine Business Overview and Total Revenue
12.4.3 Celldex Therapeutics Cholera Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Celldex Therapeutics Cholera Vaccine Products Offered
12.4.5 Celldex Therapeutics Recent Development
12.5 Merck
12.5.1 Merck Cholera Vaccine Corporation Information
12.5.2 Merck Cholera Vaccine Business Overview and Total Revenue
12.5.3 Merck Cholera Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Merck Cholera Vaccine Products Offered
12.5.5 Merck Recent Development
12.6 Ceva Asia
12.6.1 Ceva Asia Cholera Vaccine Corporation Information
12.6.2 Ceva Asia Cholera Vaccine Business Overview and Total Revenue
12.6.3 Ceva Asia Cholera Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ceva Asia Cholera Vaccine Products Offered
12.6.5 Ceva Asia Recent Development

13 Cholera Vaccine Manufacturing Cost Analysis
13.1 Cholera Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cholera Vaccine
13.4 Cholera Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cholera Vaccine Distributors List
14.3 Cholera Vaccine Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Cholera Vaccine Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Cholera Vaccine Sales (K Units) Comparison by Application (2020-2026)
Table 3. Global Market Cholera Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Cholera Vaccine Sales (K Units) by Region (2015-2020)
Table 5. Global Cholera Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Cholera Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Cholera Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Cholera Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Cholera Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Cholera Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Cholera Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Cholera Vaccine (K Units) of Key Companies (2015-2020)
Table 13. Global Cholera Vaccine Sales Share by Company (2015-2020)
Table 14. Global Cholera Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Cholera Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Cholera Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholera Vaccine as of 2019)
Table 17. Global Cholera Vaccine Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Cholera Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Cholera Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Cholera Vaccine Players
Table 22. Global Cholera Vaccine Sales (K Units) by Type (2015-2020)
Table 23. Global Cholera Vaccine Sales Share by Type (2015-2020)
Table 24. Global Cholera Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Cholera Vaccine Price (K Units) by Type (2015-2020)
Table 26. Global Cholera Vaccine Sales Share by Type (2021-2026)
Table 27. Global Cholera Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Cholera Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Cholera Vaccine Price (K Units) by Type (2021-2026)
Table 30. Global Cholera Vaccine Sales (K Units) by Application (2015-2020)
Table 31. Global Cholera Vaccine Sales Share by Application (2015-2020)
Table 32. Global Cholera Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Cholera Vaccine Price (K Units) by Application (2015-2020)
Table 34. Global Cholera Vaccine Sales (K Units) by Application (2021-2026)
Table 35. Global Cholera Vaccine Sales Share by Application (2021-2026)
Table 36. Global Cholera Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Cholera Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Cholera Vaccine Price (K Units) by Application (2021-2026)
Table 39. United States Cholera Vaccine Sales (K Units) by Company (2015-2020)
Table 40. United States Cholera Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Cholera Vaccine Sales (K Units) by Type (2015-2020)
Table 42. United States Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Cholera Vaccine Sales (K Units) by Application (2015-2020)
Table 44. United States Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Cholera Vaccine Sales (K Units) by Company (2015-2020)
Table 46. Europe Cholera Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Cholera Vaccine Sales (K Units) by Type (2015-2020)
Table 48. Europe Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Cholera Vaccine Sales (K Units) by Application (2015-2020)
Table 50. Europe Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Cholera Vaccine Sales (K Units) by Company (2015-2020)
Table 52. China Cholera Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Cholera Vaccine Sales (K Units) by Type (2015-2020)
Table 54. China Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Cholera Vaccine Sales (K Units) by Application (2015-2020)
Table 56. China Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Cholera Vaccine Sales (K Units) by Company (2015-2020)
Table 58. Japan Cholera Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Cholera Vaccine Sales (K Units) by Type (2015-2020)
Table 60. Japan Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Cholera Vaccine Sales (K Units) by Application (2015-2020)
Table 62. Japan Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Cholera Vaccine Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Cholera Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Cholera Vaccine Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Cholera Vaccine Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Cholera Vaccine Sales (K Units) by Company (2015-2020)
Table 70. India Cholera Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Cholera Vaccine Sales (K Units) by Type (2015-2020)
Table 72. India Cholera Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Cholera Vaccine Sales (K Units) by Application (2015-2020)
Table 74. India Cholera Vaccine Sales Market Share by Application (2015-2020)
Table 75. Valneva Corporation Information
Table 76. Valneva Description and Business Overview
Table 77. Valneva Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Valneva Cholera Vaccine Product
Table 79. Valneva Recent Development
Table 80. PaxVax Corporation Information
Table 81. PaxVax Description and Business Overview
Table 82. PaxVax Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. PaxVax Cholera Vaccine Product
Table 84. PaxVax Recent Development
Table 85. Shantha Biotechnics Limited Corporation Information
Table 86. Shantha Biotechnics Limited Description and Business Overview
Table 87. Shantha Biotechnics Limited Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Shantha Biotechnics Limited Cholera Vaccine Product
Table 89. Shantha Biotechnics Limited Recent Development
Table 90. Celldex Therapeutics Corporation Information
Table 91. Celldex Therapeutics Description and Business Overview
Table 92. Celldex Therapeutics Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Celldex Therapeutics Cholera Vaccine Product
Table 94. Celldex Therapeutics Recent Development
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merck Cholera Vaccine Product
Table 99. Merck Recent Development
Table 100. Ceva Asia Corporation Information
Table 101. Ceva Asia Description and Business Overview
Table 102. Ceva Asia Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Ceva Asia Cholera Vaccine Product
Table 104. Ceva Asia Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Cholera Vaccine Distributors List
Table 108. Cholera Vaccine Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Cholera Vaccine Product Picture
Figure 2. Global Cholera Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cholera Vaccine Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Scientific Research Examples
Figure 8. Others Examples
Figure 9. Global Cholera Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Cholera Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Cholera Vaccine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Cholera Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Cholera Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Cholera Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Cholera Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Cholera Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Cholera Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Cholera Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Cholera Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Cholera Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Cholera Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Cholera Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Cholera Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Cholera Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Cholera Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Cholera Vaccine Players Market Share by Revenue in Cholera Vaccine 2015 & 2019
Figure 27. Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Cholera Vaccine Revenue Share by Type (2015-2020)
Figure 29. Global Cholera Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Cholera Vaccine Revenue Share by Application (2015-2020)
Figure 31. Global Cholera Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Cholera Vaccine Sales Market Share by Type in 2019
Figure 33. United States Cholera Vaccine Sales Market Share by Type in 2019
Figure 34. Europe Cholera Vaccine Sales Market Share by Company in 2019
Figure 35. Europe Cholera Vaccine Sales Market Share by Type in 2019
Figure 36. Europe Cholera Vaccine Sales Market Share by Application in 2019
Figure 37. China Cholera Vaccine Sales Market Share by Company in 2019
Figure 38. China Cholera Vaccine Sales Market Share by Type in 2019
Figure 39. China Cholera Vaccine Sales Market Share by Application in 2019
Figure 40. Japan Cholera Vaccine Sales Market Share by Company in 2019
Figure 41. Japan Cholera Vaccine Sales Market Share by Type in 2019
Figure 42. Japan Cholera Vaccine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Cholera Vaccine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Cholera Vaccine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Cholera Vaccine Sales Market Share by Application in 2019
Figure 46. India Cholera Vaccine Sales Market Share by Company in 2019
Figure 47. India Cholera Vaccine Sales Market Share by Type in 2019
Figure 48. India Cholera Vaccine Sales Market Share by Application in 2019
Figure 49. Valneva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. PaxVax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Shantha Biotechnics Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Celldex Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Ceva Asia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Cholera Vaccine
Figure 57. Manufacturing Process Analysis of Cholera Vaccine
Figure 58. Cholera Vaccine Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed